Publications by authors named "Ingrid Hammermeister Nezu"
Article Synopsis
- * The WHO published the first COVID-19 Weekly Epidemiological Update on August 17, 2020, and continued until the final edition on September 1, 2023, after which updates transitioned to a comprehensive format every 4 weeks.
- * The article reviews the WEU's data collection and publication process, its global impact, and offers recommendations to improve collaboration and information sharing for future health crises.
Article Synopsis
- The 2022-2023 mpox outbreak mainly impacted adult men, with only 1.3% of cases occurring in children and teens under 18.
- In the analyzed data, there was only one ICU admission for children and no recorded deaths in that age group.
- Different age groups experienced various transmission routes and clinical symptoms during the outbreak.
Article Synopsis
- The WHO developed an alert system from May 2021 to June 2022 to assess and respond to public health risks related to COVID-19, analyzing data from 237 countries.
- A three-stage mixed methods approach was utilized to predict future deaths and adjust alert levels based on context, leading to the creation of a watchlist for countries needing assistance.
- The system facilitated significant support, including over $27 million in emergency funding and medical supplies, while demonstrating the potential for similar future applications in managing outbreaks.
Article Synopsis
- COVID-19, caused by SARS-CoV-2, was declared a public health emergency in January 2020, with early studies showing that over 80% of deaths were among individuals aged 60 and older.
- The World Health Organization developed strategies to prioritize vaccine distribution, emphasizing the importance of vaccinating at-risk populations, particularly older adults, aiming for full vaccination coverage.
- Data analysis revealed that people aged 60 and above made up more than 80% of COVID-19 deaths globally, with significant mortality impact seen in lower and middle-income countries, highlighting the urgency for effective vaccine rollout.*